- Home
- NMAI vs TCMD Comparison
NMAI vs TCMD Comparison
Compare NMAI & TCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMAI
- TCMD
- Stock Information
- Founded
- NMAI 2021
- TCMD 1995
- Country
- NMAI United States
- TCMD United States
- Employees
- NMAI N/A
- TCMD N/A
- Industry
- NMAI Investment Managers
- TCMD Medical/Dental Instruments
- Sector
- NMAI Finance
- TCMD Health Care
- Exchange
- NMAI Nasdaq
- TCMD Nasdaq
- Market Cap
- NMAI 382.1M
- TCMD 314.0M
- IPO Year
- NMAI N/A
- TCMD 2016
- Fundamental
- Price
- NMAI $12.44
- TCMD $10.00
- Analyst Decision
- NMAI
- TCMD Hold
- Analyst Count
- NMAI 0
- TCMD 3
- Target Price
- NMAI N/A
- TCMD $16.00
- AVG Volume (30 Days)
- NMAI 74.8K
- TCMD 482.1K
- Earning Date
- NMAI 01-01-0001
- TCMD 05-05-2025
- Dividend Yield
- NMAI 13.14%
- TCMD N/A
- EPS Growth
- NMAI N/A
- TCMD N/A
- EPS
- NMAI 0.64
- TCMD 0.66
- Revenue
- NMAI N/A
- TCMD $293,164,000.00
- Revenue This Year
- NMAI N/A
- TCMD $7.96
- Revenue Next Year
- NMAI N/A
- TCMD $8.53
- P/E Ratio
- NMAI $19.03
- TCMD $14.96
- Revenue Growth
- NMAI N/A
- TCMD 5.96
- 52 Week Low
- NMAI $10.60
- TCMD $8.61
- 52 Week High
- NMAI $12.55
- TCMD $21.10
- Technical
- Relative Strength Index (RSI)
- NMAI 64.61
- TCMD 36.80
- Support Level
- NMAI $12.19
- TCMD $9.81
- Resistance Level
- NMAI $12.37
- TCMD $10.29
- Average True Range (ATR)
- NMAI 0.12
- TCMD 0.41
- MACD
- NMAI -0.00
- TCMD 0.11
- Stochastic Oscillator
- NMAI 88.90
- TCMD 50.00
About NMAI Nuveen Multi-Asset Income Fund of Beneficial Interest
Nuveen Multi-Asset Income Fund is a closed-end management investment company. The Fund dynamically invests in a portfolio of equity and debt securities of issuers located around the world. This dynamic investment strategy uses a risk-based framework in which any amount can be allocated to an asset-class at any time. The Fund may invest in equity and debt securities of any type without limit.
About TCMD Tactile Systems Technology Inc.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.